Abstract
Traditionally, type 1 diabetes (T1D) has been thought of as a disease of cellular immunity, but there is increasing evidence that components of the innate immune system, controlled largely by Toll-like receptors (TLRs), play a significant role in T1D development. TLRs are pattern-recognition molecules on immune cells that recognize pathogens, leading to the production of cytokines such as interleukin-1β (IL1β, encoded by the IL1B gene). IL1β is increased in patients with newly diagnosed T1D and likely acts as an early inflammatory signal in T1D development. Because hyperglycemia is a hallmark of T1D, the effects of hyperglycemia on IL1β expression in peripheral blood mononuclear cells (PBMCs) and islet cells have been examined, but with inconsistent results, and the mechanisms leading to this increase remain unknown. Fatty acids stimulate IL1β expression and may promote inflammation, causing hyperglycemia and insulin resistance. The mechanisms by which IL1β is involved in T1D pathogenesis are controversial. Overall, studies in pancreatic β-cells suggest that IL1β-mediated damage to islet cells involves multiple downstream targets. Potential therapies to decrease the progression of T1D based on IL1β biology include pioglitazone, glyburide, IL1 receptor antagonists, and agents that remove IL1β from the circulation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Atkinson MA, Maclaren NK . The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994;331:1428–36.
Bach JF . Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994;15:516–42.
Donath MY, Størling J, Maedler K, Mandrup-Poulsen T . Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 2003;81:455–70.
Mathis D, Vence L, Benoist C . beta-Cell death during progression to diabetes. Nature 2001;414:792–8.
Shimabukuro M, Koyama K, Lee Y, Unger RH . Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. J Clin Invest 1997;100:1750–4.
Martinon F, Gaide O, Pétrilli V, Mayor A, Tschopp J . NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 2007;29:213–29.
Leiter EH . Murine macrophages and pancreatic beta cells. Chemotactic properties of insulin and beta-cytostatic action of interleukin 1. J Exp Med 1987;166:1174–9.
Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC . Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007;92:3705–11.
Meyers AJ, Shah RR, Gottlieb PA, Zipris D . Altered Toll-like receptor signaling pathways in human type 1 diabetes. J Mol Med 2010;88:1221–31.
Ururahy MA, Loureiro MB, Freire-Neto FP, et al. Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria. Pediatr Diabetes 2012; 13:147–54.
Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK . Serum IL-1β, IL-2, and IL-6 in insulin-dependent diabetic children. Mediators Inflamm 2006;2006:59206.
Bradshaw EM, Raddassi K, Elyaman W, et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 2009;183:4432–9.
Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I . High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008;57:3090–8.
Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ . Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol 2008;180:1929–37.
Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, Galassetti PR . Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes 2008;9:9–16.
Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A . Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988;240:1546–8.
Valencia JV, Mone M, Koehne C, Rediske J, Hughes TE . Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 2004;47:844–52.
Böni-Schnetzler M, Thorne J, Parnaud G, et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 2008;93:4065–74.
Welsh N, Cnop M, Kharroubi I, et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 2005;54:3238–44.
Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110:851–60.
Stegenga ME, van der Crabben SN, Dessing MC, et al. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008;25:157–64.
Maedler K, Sergeev P, Ehses JA, et al. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci USA 2004;101:8138–43.
Jackson A, McWilliams C, Kaizer E, et al. Gene expression profiling of human pancreatic islets undergoing a simulated process of instant blood-mediated inflammatory reaction. Transplant Proc 2008;40:430–2.
Zeender E, Maedler K, Bosco D, Berney T, Donath MY, Halban PA . Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. J Clin Endocrinol Metab 2004;89:5059–66.
Gurzov EN, Ortis F, Cunha DA, et al. Signaling by IL-1beta+IFN-gamma and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ 2009;16:1539–50.
Gurzov EN, Germano CM, Cunha DA, et al. p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic beta-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 2010;285:19910–20.
Makeeva N, Myers JW, Welsh N . Role of MKK3 and p38 MAPK in cytokine-induced death of insulin-producing cells. Biochem J 2006;393(Pt 1):129–39.
Ammendrup A, Maillard A, Nielsen K, et al. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 2000;49:1468–76.
Akerfeldt MC, Howes J, Chan JY, et al. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 2008;57:3034–44.
Heitmeier MR, Arnush M, Scarim AL, Corbett JA . Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes. J Biol Chem 2001;276:11151–8.
Ma Z, Landt M, Bohrer A, Ramanadham S, Kipnis DM, Turk J . Interleukin-1 reduces the glycolytic utilization of glucose by pancreatic islets and reduces glucokinase mRNA content and protein synthesis by a nitric oxide-dependent mechanism. J Biol Chem 1997;272:17827–35.
Ohara-Imaizumi M, Cardozo AK, Kikuta T, Eizirik DL, Nagamatsu S . The cytokine interleukin-1beta reduces the docking and fusion of insulin granules in pancreatic beta-cells, preferentially decreasing the first phase of exocytosis. J Biol Chem 2004;279:41271–4.
del Rey A, Besedovsky H . Antidiabetic effects of interleukin 1. Proc Natl Acad Sci USA 1989;86:5943–7.
Ospelt C, Gay S . TLRs and chronic inflammation. Int J Biochem Cell Biol 2010;42:495–505.
Krishnan J, Lee G, Choi S . Drugs targeting Toll-like receptors. Arch Pharm Res 2009;32:1485–502.
Chun E, Lee SH, Lee SY, et al. Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. J Clin Immunol 2010;30:459–64.
Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK . The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 2008;125:145–53.
Huang QQ, Pope RM . The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep 2009;11:357–64.
Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I . Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008;93:578–83.
Du T, Zhou ZG, You S, et al. Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta 2009;402:133–8.
Kiura K, Kataoka H, Yasuda M, Inoue N, Shibata K . The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses. FEMS Immunol Med Microbiol 2006;48:44–55.
Karumuthil-Melethil S, Perez N, Li R, Vasu C . Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J Immunol 2008;181:8323–34.
Kim HS, Han MS, Chung KW, et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007;27:321–33.
Ehses JA, Meier DT, Wueest S, et al. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 2010;53:1795–806.
Deopurkar R, Ghanim H, Friedman J, et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010;33:991–7.
Lee JY, Zhao L, Youn HS, et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004;279:16971–9.
Lee JY, Sohn KH, Rhee SH, Hwang D . Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001;276:16683–9.
Lee SM, Choi SE, Lee JH, et al. Involvement of the TLR4 (Toll-like receptor4) signaling pathway in palmitate-induced INS-1 beta cell death. Mol Cell Biochem 2011;354:207–17.
Kharroubi I, Ladrière L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL . Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004;145:5087–96.
Böni-Schnetzler M, Boller S, Debray S, et al. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 2009;150:5218–29.
Azad K, Parkin JM, Court S, Laker MF, Alberti KG . Circulating lipids and glycaemic control in insulin dependent diabetic children. Arch Dis Child 1994;71:108–13.
Schroder K, Zhou R, Tschopp J . The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010;327:296–300.
Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA . IL-1β processing in host defense: beyond the inflammasomes. PLoS Pathog 2010;6:e1000661.
Wittmann M, Kingsbury SR, McDermott MF . Is caspase 1 central to activation of interleukin-1? Joint Bone Spine 2011;78:327–30.
Pontillo A, Brandao L, Guimaraes R, Segat L, Araujo J, Crovella S . Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmunity 2010;43:583–9.
Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J . Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010;11:136–40.
Masters SL, Dunne A, Subramanian SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1ß in type 2 diabetes. Nat Immunol 2010;11:897–904.
Masson E, Koren S, Razik F, et al. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice. Am J Physiol Endocrinol Metab 2009;296:E1251–61.
Westwell-Roper C, Dai DL, Soukhatcheva G, et al. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011;187:2755–65.
Wen H, Gris D, Lei Y, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011;12:408–15.
Schott WH, Haskell BD, Tse HM, et al. Caspase-1 is not required for type 1 diabetes in the NOD mouse. Diabetes 2004;53:99–104.
Dasu MR, Park S, Devaraj S, Jialal I . Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology 2009;150:3457–64.
Lamkanfi M, Mueller JL, Vitari AC, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 2009;187:61–70.
Schwarznau A, Hanson MS, Sperger JM, et al. IL-1beta receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis. J Cell Physiol 2009;220:341–7.
Nicoletti F, Di Marco R, Barcellini W, et al. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol 1994;24:1843–7.
Sandberg JO, Eizirik DL, Sandler S . IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice. Clin Exp Immunol 1997;108:314–7.
Sumpter KM, Adhikari S, Grishman EK, White PC . Preliminary studies related to anti-interleukin-1ß therapy in children with newly diagnosed type 1 diabetes. Pediatr Diabetes 2011;12:656–67.
Acknowledgements
We thank Michele Hutchison for assistance in creating the figure.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Table S1.
(DOC 123 kb)
Rights and permissions
About this article
Cite this article
Grishman, E., White, P. & Savani, R. Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes. Pediatr Res 71, 626–632 (2012). https://doi.org/10.1038/pr.2012.24
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2012.24
This article is cited by
-
High glucose enhances the activation of NLRP3 inflammasome by ambient fine particulate matter in alveolar macrophages
Particle and Fibre Toxicology (2023)
-
Prenatal and early life factors and type 1 diabetes
Endocrine (2022)
-
Visualization and modeling of inhibition of IL-1β and TNF-α mRNA transcription at the single-cell level
Scientific Reports (2021)
-
Long-term exposures to ethion and endotoxin cause lung inflammation and induce genotoxicity in mice
Cell and Tissue Research (2019)
-
NLRP3 inflammasome is expressed and regulated in human islets
Cell Death & Disease (2018)
